Important Safety Information | Full Prescribing Information | Patient Support Program | Send to a Friend   
    FOSRENOL®
About High Phosphorus Levels
Why FOSRENOL® ?
Treating Your Condition
Patient & Caregiver Resources
Exclusive Offers
Patient Support Program
Media Center
Patient & Caregiver Resources
Helpful Resources for People With Chronic Kidney Disease and Their Caregivers
Register for Exclusive Offers
Exclusive Offers to Help Patients Dealing With Chronic Kidney Disease
Patient Support Program
FOSRENOL® | at hand Is Designed to Provide Assistance to Patients Taking FOSRENOL®
Treating Your Condition
Hyperphosphatemia may be a condition that requires long-term treatment. You should take FOSRENOL® according to your physician’s instructions, to keep your

phosphorus levels

under control, and discuss your treatment regularly with your physician. FOSRENOL® can be effective and is generally well tolerated in people who take the medication as prescribed.

Maintenance of reduction of phosphorus levels was observed for up to 3 years in patients treated with FOSRENOL® in long-term, open label extensions. It is important to continue phosphate binder treatment so your phosphorus doesn’t return to pretreatment levels.

We offer the following resources to help you:

Please talk to your healthcare professional if you have any questions about your condition or your medications. We also recommend you consult the many fine organizations that provide support to people with kidney disease and their families.

The most common adverse events were gastrointestinal, such as nausea and vomiting, and generally went away over time with continued dosing.


This site is strictly intended for US residents and is governed solely by US laws and governmental regulations. Please see our online privacy policy for more information.
©2008 Shire US Inc., Wayne, PA 19087-5367
(800) 828-2088. All rights reserved.

While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.
Contact Us | Privacy Policy | Unsubscribe
FOS1726 1/15/2008